Claus Gmbh

Publication No. WO/2008/104385 Published on Sept. 4, Assigned to Abbott for Amyloidose Treatment Method (German, Swiss Inventors)
US Fed News Service, Including US State News; 11/9/2009; 398 words; ...Ulrich Ebert, Heinz Hillen, Gerhard Gross, Andreas Draguhn, Claus Bruhl and Christiane Grimm - all from Germany, and Carsten...treatment of amyloidoses. The patent has been assigned to Abbott GmbH & Co. KG, Wiesbaden, Germany. According to an abstract...

Publication No. WO/2008/125382 Published on Oct. 23, Assigned to Continental Automotive for Exhaust Gas Turbocharger (German Inventors)
US Fed News Service, Including US State News; 11/5/2009; 404 words; GENEVA, Nov. 7 -- Ralf Boning, Hartmut Claus, Dirk Frankenstein, Holger Fath, Jochen Held, Stefan Krauss...turbocharger. The patent has been assigned to Continental Automotive GmbH, Hannover, Germany. According to an abstract posted by the...

Publication No. WO/2009/129859 Published on Oct. 29, Assigned to Dr. Gerhard Mann Chem.-pharm. Fabrik for Eye Health Maintaining, Strengthening, Improving, Promoting Composition, Method (German Inventors)
US Fed News Service, Including US State News; 10/30/2009; 438 words; ...Oct. 31 -- Christoph Kessler, Gunther Bellmann and Gudrun Claus-herz, all from Germany, have developed compositions and...has been assigned to Dr. Gerhard Mann Chem.-pharm. Fabrik Gmbh, Berlin. According to an abstract posted by the World Intellectual...

Publication No. WO/2009/127457 Published on Oct. 22, Assigned to Titech Antriebssysteme for Tubular Article Production Method (German Inventors)
US Fed News Service, Including US State News; 10/28/2009; 580 words; GENEVA, Oct. 22 -- Marko Schleicher, Claus-Luder Mahnken, Henning Kanzow and Siegmar Gebhardt, all from...tube. The patent has been assigned to Contitech Antriebssysteme Gmbh, Hannover, Germany. According to an abstract posted by the...

Pieris Reports Preclinical Development Progress of its Next Generation VEGF Antagonist.
Angiogenesis Weekly; 10/23/2009; 656 words; ...Factor). Under its manufacturing agreement with Wacker Biotech GmbH, a full-service contract manufacturer of biopharmaceuticals...twelve months. Commenting on these developments at Pieris, Claus Schalper, interim-CEO, said: "Sustained progress in development...